As part of UAB’s Research Strategic Initiative, myUABResearch Phase 1 will be live on Dec. 15.  Effective Dec. 15, how you submit grants, agreements, financial disclosures and pre-approval/external activity requests will change. 

The latest cohort selected for the Blaze Leadership Academy includes 20 faculty and staff from across campus. See the full list of participants in this story.

The University-Wide Interdisciplinary Research Center focuses on the involvement of community members, organizations and patients as partners in research and interventions with a mission to prevent disease and improve health for all.

More than 100 faculty and staff are driving progress through their membership in the six working groups of the UAB Research Strategic Initiative. Learn more about their progress in recent months.

UAB researchers are studying knee osteoarthritis, a condition that will affect nearly half of Americans as they age, using new diagnostic tools. The pioneering research is now enrolling younger participants, starting at age 45.

The Academic Research Organization for Clinical Trials, or ARO-CT, has been established to support the expanding infrastructure needs of UAB’s clinical trials enterprise as part of the university’s Research Strategic Initiative.

Forty UAB inventors were named on 17 patents in fiscal year 2024. Through the new patent coin recognition program from UAB’s Harbert Institute for Innovation and Entrepreneurship, these faculty and staff, along with patent holders moving forward, are receiving special tokens honoring their hard work and dedication.

Learn more about the initiative’s progress in this article and make plans to attend the town hall meeting at 10 a.m. March 19 for updates and questions with President Watts, Vice President Brown and working group leaders.

Ronald Lazar, Ph.D., director of UAB’s Evelyn F. McKnight Brain Institute, explains effective interventions, the importance of choice and why you should start where you are.

A study published in December 2024 demonstrates how natural language processing techniques, combined with dedicated human personnel, can flag unusual findings in radiology images and connect patients with follow-up care. The work, pioneered in nodules on the adrenal glands, has many applications, the researchers say.

Significant updates to the Genomic Data Sharing Policy will take effect Jan. 25. The change affects new and renewed requests for data access from 20 NIH-supported data repositories. Learn more about how this affects UAB researchers in this article.

Attend a town hall at the Alumni House at 10 a.m. March 19, 2025, for an important update on UAB’s Research Strategic Initiative: Growth with Purpose.

Many studies have linked childbearing to a lower risk of being diagnosed with Alzheimer’s disease and dementia later in life. But in a new study, UAB sociologists found that early-life factors, including a woman’s socioeconomic status in adolescence, accounted for the apparent pregnancy-cognitive connection.

The $1 million project to install the university’s first bulk dry heat sterilizer was made possible through a grant from the NIH and internal investments as part of the Research Strategic Initiative: Growth with Purpose. Dry heat sterilization is more efficient and saves power and water.

After studying thousands of hours of data from heart rate monitors, UAB clinician-researchers developed algorithms to predict when a baby’s heart rate will drop to unsafe levels in the NICU. With funding from UAB’s Harbert Institute, they will now conduct a clinical trial of a device they have created to intervene automatically.

A 3D printer for prosthetics, navigation for patients on dialysis and a new electron microscope are three of the 11 projects to receive funding. The HSF-GEF faculty grants program is a way for UAB to support innovative ideas from its researchers and clinicians.

After an extensive national search, UAB has named Kevyn E. Merten, Ph.D., as the senior associate vice president for Research Operations, effective Jan. 14. Merten will be responsible for the day-to-day operations of the Office of Research. He joins UAB from the University of Louisville.

Six working groups have been meeting to address infrastructure opportunities that will help UAB expand its research impact and expenditures through the Research Strategic Initiative: Growth with Purpose. Read more about how the groups were selected, their progress and next steps.

The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and Metabolism Research Institute and the Center for Diabetes and Metabolic Diseases at Indiana University.

From a 3 Tesla PET/MR to a 0.55 Tesla Freemax, this core facility offers research tools that are crucial to UAB’s neuroscience studies and more, as well as expert advice on the best protocols to use for individual experiments.